Exscientia

$11.32 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Exscientia

Exscientia Limited, formerly Exscientia Holdings Limited, is an artificial intelligence-driven pharmaceutical technology (pharmatech) company. The Company's focus is on the discovery, design and development of small molecule drug candidates. The Company has built a complete end-to-end solution of artificial intelligence (AI), and experimental technologies for target identification, drug candidate design, translational models and patient selection. Its AI process is comprised of the four elements: Precision Target, Precision Design, Precision Experiment and Precision Medicine. Its AI-design includes a range of deep learning and machine learning algorithms, generative methods, active learning and natural language processing. These methods are used to guide target selection, to design the precise molecular architecture of potential drug molecules and to analyze patient tissues to prioritize the molecules. The Company's lead drug candidate, EXS21546, is in early stage of development.

Stock Analysis

last close $11.32
1-mo return 0.2%
3-mo return 28.2%
avg daily vol. 113.04T
52-week high 30.38
52-week low 6.56
market cap. $1.5B
forward pe -
annual div. -
roe -15.7%
ltg forecast -
dividend yield -
annual rev. $27M
inst own. 21.3%
baraka

Subscribe now for daily local and international financial news

Subscribe